Australia markets closed

Cyclo Therapeutics, Inc. (CYTH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.5100+0.0400 (+2.72%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-20,057
-20,057
-15,451
-14,287
-8,942
Depreciation & amortisation
19.276
19.276
19.481
16.827
12.763
Stock-based compensation
736.915
736.915
513.569
470.876
271.308
Change in working capital
3,063
3,063
-48.151
-1,228
116.075
Accounts receivable
-67.388
-67.388
427.85
-444.023
71.14
Inventory
-52.783
-52.783
-27.054
10.472
4.721
Other working capital
-16,187
-16,187
-15,129
-15,028
-8,593
Other non-cash items
80.69
-
-
-
-
Net cash provided by operating activities
-16,185
-16,185
-15,114
-15,005
-8,540
Cash flows from investing activities
Investments in property, plant and equipment
-2.42
-2.42
-15.086
-22.5
-53.127
Other investing activities
-
-
53.256
37.322
39.079
Net cash used for investing activities
-2.42
-2.42
38.17
14.822
-14.048
Cash flows from financing activities
Debt repayment
0
0
-8.159
-6.778
-
Common stock issued
9,739
9,739
0
18,764
18,458
Other financing activities
9,354
9,354
-
-
-
Net cash used provided by (used for) financing activities
23,891
23,891
6.778
18,757
18,617
Net change in cash
7,703
7,703
-15,069
3,767
10,062
Cash at beginning of period
1,543
1,543
16,613
12,846
2,784
Cash at end of period
9,247
9,247
1,543
16,613
12,846
Free cash flow
Operating cash flow
-16,185
-16,185
-15,114
-15,005
-8,540
Capital expenditure
-2.42
-2.42
-15.086
-22.5
-53.127
Free cash flow
-16,187
-16,187
-15,129
-15,028
-8,593